Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002037625 | SCV002234875 | pathogenic | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2023-03-08 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with Niemann-Pick disease type B (PMID: 8664904). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 248 of the SMPD1 protein (p.Glu248Gln). This variant is present in population databases (no rsID available, gnomAD 0.0009%). ClinVar contains an entry for this variant (Variation ID: 1452305). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 8664904). This variant disrupts the p.Glu248 amino acid residue in SMPD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15221801, 19411774). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |